Independence Bank of Kentucky’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
AIM
AAMU
ECSS
ADEF
Independence Bank of Kentucky's BIIB Position: Q2 2026 in Review
Independence Bank of Kentucky held its Biogen (BIIB) position steady in Q2 2026 at 100 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #462.
Independence Bank of Kentucky first reported a position in BIIB in Q4 2017 and has held it in 35 quarters since. The position peaked at $56K in Q4 2017. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Independence Bank of Kentucky held 100 shares of Biogen worth $21.6K as of Q2 2026.
- Independence Bank of Kentucky left its Biogen share count unchanged in Q2 2026.
- Biogen made up ﹤0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #462 holding.
- Independence Bank of Kentucky first reported a position in Biogen in Q4 2017 and has held it in 35 quarters since.
- Independence Bank of Kentucky's Biogen position peaked at $56K in Q4 2017.
- 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.